These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21982686)

  • 21. The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
    Park SB; Lin CS; Krishnan AV; Kiernan MC
    Cancer Chemother Pharmacol; 2011 May; 67(5):1189-90; author reply 1191-2. PubMed ID: 21327679
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.
    Terrazzino S; Argyriou AA; Cargnin S; Antonacopoulou AG; Briani C; Bruna J; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Kalofonos HP; Canonico PL; Genazzani AA; Cavaletti G
    J Peripher Nerv Syst; 2015 Mar; 20(1):15-23. PubMed ID: 25858589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] ].
    Iñiguez C; Larrodé P; Mayordomo JI; Mauri JA; Trés A; Morales F
    Neurologia; 2000 Oct; 15(8):343-51. PubMed ID: 11143501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes.
    Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CS; Krishnan AV; Lewis CR; Kiernan MC
    BMC Cancer; 2014 Dec; 14():993. PubMed ID: 25535399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.
    Pagani M
    Med Clin North Am; 2010 Jul; 94(4):835-52, xiii. PubMed ID: 20609866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial disease mimicking Charcot-Marie Tooth disease.
    Needham M; Duley J; Hammond S; Herkes GK; Hirano M; Sue CM
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):99-100. PubMed ID: 17172573
    [No Abstract]   [Full Text] [Related]  

  • 27. CBDCA: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxaliplatin induced-neuropathy in digestive tumors.
    Sereno M; Gutiérrez-Gutiérrez G; Gómez-Raposo C; López-Gómez M; Merino-Salvador M; Tébar FZ; Rodriguez-Antona C; Casado E
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):166-78. PubMed ID: 24029604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer.
    Martino MA; Miller E; Grendys EC
    Gynecol Oncol; 2005 May; 97(2):710-2. PubMed ID: 15863189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-induced Evan's syndrome.
    Earle CC; Chen WY; Ryan DP; Mayer RJ
    Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted Sequencing Reveals Low-Frequency Variants in
    Apellániz-Ruiz M; Tejero H; Inglada-Pérez L; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; Castelo B; Redondo A; García-Donás J; Romero-Laorden N; Sereno M; Merino M; Currás-Freixes M; Montero-Conde C; Mancikova V; Åvall-Lundqvist E; Green H; Al-Shahrour F; Cascón A; Robledo M; Rodríguez-Antona C
    Clin Cancer Res; 2017 Mar; 23(5):1227-1235. PubMed ID: 27582484
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.
    Hertz DL; Roy S; Jack J; Motsinger-Reif AA; Drobish A; Clark LS; Carey LA; Dees EC; McLeod HL
    Breast Cancer Res Treat; 2014 May; 145(1):245-54. PubMed ID: 24706167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
    Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
    Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonic seizures in a patient with Charcot-Marie-tooth disease.
    Piantino JA; Torres A
    Pediatr Neurol; 2007 Feb; 36(2):118-20. PubMed ID: 17275665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia.
    Sissung TM; Mross K; Steinberg SM; Behringer D; Figg WD; Sparreboom A; Mielke S
    Eur J Cancer; 2006 Nov; 42(17):2893-6. PubMed ID: 16950614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of diabetes on oxaliplatin-induced peripheral neuropathy.
    Uwah AN; Ackler J; Leighton JC; Pomerantz S; Tester W
    Clin Colorectal Cancer; 2012 Dec; 11(4):275-9. PubMed ID: 22682776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.
    Kulkarni AA; Boora G; Kanwar R; Ruddy KJ; Banck MS; Le-Lindqwister N; Therneau TM; Loprinzi CL; Beutler AS
    Acta Oncol; 2015; 54(8):1227-9. PubMed ID: 25549536
    [No Abstract]   [Full Text] [Related]  

  • 40. Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
    Argyriou AA; Cavaletti G; Antonacopoulou A; Genazzani AA; Briani C; Bruna J; Terrazzino S; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Psaromyalou A; Angelopoulou A; Kalofonos HP
    Cancer; 2013 Oct; 119(19):3570-7. PubMed ID: 23821303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.